Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Lycett, K, Juonala, M, Lau, T, Grobler, A, Kerr, JA, Magnussen, C, Sabin, MA, Burgner, DP, Wake, M.
Early clinical markers of overweight/obesity onset and resolution by adolescence: Longitudinal Study of Australian Children.
Obesity Research & Clinical Practice
13(3)
:
253
2019
view publication
Bell, LA, Vuillermin, P, Burgner, D, Timperio, A, Hesketh, K.
Physical activity, adiposity and functional vascular parameters in preschool aged children: a cross-sectional study.
Obesity Research & Clinical Practice
13(3)
:
314
2019
view publication
Liu, M, Lycett, K, Burgner, D, Wake, M.
Obesity and retinal microvasculature in mid-childhood and mid-life: The Longitudinal Study of Australian Children.
Obesity Research & Clinical Practice
13(3)
:
310
2019
view publication
Saner, CCS, Harcourt, BBH, Wake, MMW, Juonala, MMJ, Kao, K-TKKT, Saffery, RRS, Burgner, DDB, Sabin, MMS.
Glycoprotein acetyls (GlycA) associate with BMI and co-morbidities in childhood obesity.
Obesity Research & Clinical Practice
13(3)
:
292 -293
2019
view publication